Want to see IN:HERANBA full AI Analyst Report?
Top Page
Heranba Industries Limited
(HERANBA)
Select Model
Select Model
Rating:42Neutral
Price Target:
₹171.00
▼(-29.76% Downside)
Action:Reiterated
Date:05/30/26
The score is primarily weighed down by weakened financial performance (losses, higher leverage, and negative operating/free cash flow) and a bearish technical setup (below key moving averages with negative MACD). Valuation provides limited support due to negative earnings and a low dividend yield.
Positive Factors
Diversified product and market mix
A broad portfolio across insecticides, herbicides, fungicides and PGRs plus domestic and export channels provides structural demand diversification. This reduces single-crop seasonality and customer concentration, supporting steadier volumes and resilience in revenue sources over the medium term.
Negative Factors
Sharp profitability deterioration
The swing to a large net loss and negative operating profit signals structural margin and demand stress. Persistent losses erode retained earnings and constrain reinvestment, weakening competitive position and making it harder to fund growth or absorb future shocks without corrective action.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified product and market mix
A broad portfolio across insecticides, herbicides, fungicides and PGRs plus domestic and export channels provides structural demand diversification. This reduces single-crop seasonality and customer concentration, supporting steadier volumes and resilience in revenue sources over the medium term.
Read all positive factors
Heranba Industries Limited (HERANBA) vs. iShares MSCI India ETF (INDA)
Market Cap
₹7.54B
Dividend Yield0.39%
Average Volume (3M)3.99K
Price to Earnings (P/E)―
Beta (1Y)1.68
Revenue GrowthN/A
EPS GrowthN/A
CountryIN
Employees1,250
SectorBasic Materials
Sector Strength58
IndustryAgricultural Inputs
Share Statistics
EPS (TTM)-11.75
Shares Outstanding40,013,466
10 Day Avg. Volume4,133
30 Day Avg. Volume3,992
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.83
Price to Sales (P/S)0.40
P/FCF Ratio-2.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Heranba Industries Limited Business Overview & Revenue Model
Company Description
Heranba Industries Limited, headquartered in Mumbai, India, specializes in the manufacturing, marketing, and sale of a comprehensive range of agrochemicals. The company's extensive product portfolio includes essential intermediate chemicals (e.g.,...
How the Company Makes Money
Heranba makes money primarily by selling agrochemical formulations used for crop protection. Its revenue is mainly generated from (1) domestic sales of branded and/or distributed crop protection products to agricultural input channels (such as dis...
Heranba Industries Limited Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
48
Neutral
Cash Flow
27
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.53B | 15.95B | 14.17B | 12.49B | 13.11B | 14.35B |
| Gross Profit | 5.14B | 2.80B | 4.72B | 3.70B | 4.29B | 5.04B |
| EBITDA | 897.33M | 692.40M | 1.05B | 886.70M | 1.68B | 2.79B |
| Net Income | -472.10M | -764.20M | 30.70M | 348.90M | 1.04B | 1.89B |
Balance Sheet | ||||||
| Total Assets | 21.84B | 19.70B | 18.13B | 14.80B | 11.62B | 10.69B |
| Cash, Cash Equivalents and Short-Term Investments | 429.90M | 355.50M | 426.00M | 287.00M | 1.22B | 1.05B |
| Total Debt | 5.13B | 5.76B | 3.49B | 1.65B | 930.00M | 539.62M |
| Total Liabilities | 13.33B | 12.00B | 9.63B | 6.27B | 3.52B | 3.54B |
| Stockholders Equity | 8.42B | 7.62B | 8.41B | 8.43B | 8.10B | 7.14B |
Cash Flow | ||||||
| Free Cash Flow | -1.49B | -2.32B | -1.75B | -1.46B | 611.90M | 176.37M |
| Operating Cash Flow | -1.22B | -1.40B | 1.01B | 1.07B | 1.23B | 981.75M |
| Investing Cash Flow | -265.00M | -902.30M | -2.39B | -2.41B | -1.00B | -816.79M |
| Financing Cash Flow | 1.35B | 2.11B | 1.52B | 620.20M | -180.80M | -62.80M |
Heranba Industries Limited Technical Analysis
Neutral
243.45
Price Trends
196.56
Negative
196.86
Negative
232.87
Negative
Market Momentum
-1.75
Negative
51.05
Neutral
37.19
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:HERANBA, the sentiment is Neutral. The current price of 243.45 is above the 20-day moving average (MA) of 185.29, above the 50-day MA of 196.56, and above the 200-day MA of 232.87, indicating a neutral trend. The MACD of -1.75 indicates Negative momentum. The RSI at 51.05 is Neutral, neither overbought nor oversold. The STOCH value of 37.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:HERANBA.
Heranba Industries Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ₹82.18B | 11.80 | ― | 1.02% | 21.94% | 123.70% | |
71 Outperform | ₹49.79B | 17.09 | ― | 0.17% | -0.75% | -2.74% | |
71 Outperform | ₹250.45B | 40.55 | ― | 0.26% | 2.85% | 7.41% | |
68 Neutral | ₹19.31B | 13.47 | ― | 0.71% | 6.98% | 1.57% | |
64 Neutral | ₹44.39B | 24.05 | ― | 0.92% | 8.79% | 47.20% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
42 Neutral | ₹7.54B | -9.66 | ― | 0.39% | ― | ― |
* Basic Materials Sector Average
IN:HERANBA
Heranba Industries Limited
188.50
-183.46
-49.32%
IN:DHANUKA
Dhanuka Agritech Limited
1,092.45
-613.78
-35.97%
IN:INSECTICID
Insecticides (India) Limited
663.70
-291.13
-30.49%
IN:RALLIS
Rallis India Limited
228.25
-82.96
-26.66%
IN:SHARDACROP
Sharda Cropchem Ltd.
910.85
66.08
7.82%
IN:SUMICHEM
Sumitomo Chemical India Ltd.
501.75
-51.72
-9.34%
Heranba Industries Limited Corporate Events
Heranba Publishes FY26 Financial Results in Multiple Newspapers
May 30, 2026
Heranba Industries Limited has announced that its audited financial results for the quarter and full year ended 31 March 2026, which were approved by the board on 28 May 2026, have been published in multiple regional and national newspapers. The p...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.